Recap: Laboratory Corp Q2 Earnings

 

Shares of Laboratory Corp LH remained unaffected after the company reported Q2 results.

Quarterly Results

Earnings per share increased 138.52% over the past year to $6.13, which beat the estimate of $5.57.

Revenue of $3,841,000,000 up by 38.71% from the same period last year, which beat the estimate of $3,610,000,000.

Outlook

Laboratory Corp hasn't issued any earnings guidance for the time being.

Laboratory Corp hasn't issued any revenue guidance for the time being.

Conference Call Details

Date: Jul 29, 2021

Time: 09:00 AM

ET Webcast URL: https://edge.media-server.com/mmc/p/h74o5cxg

Price Action

Company's 52-week high was at $285.82

Company's 52-week low was at $170.05

Price action over last quarter: Up 6.51%

Company Overview

Laboratory Corporation of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing. With the addition of Covance, LabCorp also has a sizable footprint in the global contract research organization market.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!